Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02801877 · ClinicalTrials.gov registry record · NA
IntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for Depression
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 301
- Enrollment target
NCT02801877 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 301 participants.
The verdict
NCT02801877, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 301 participants
- Enrollment target
Study Summary
This study will evaluate and compare a smartphone intervention for depression and anxiety that uses machine learning to tailor treatment for participants with the same intervention without the machine learning component. The intervention, referred to as IntelliCare, delivers participant-specific treatment material and motivational messaging via a mobile phone to help individuals with depression and/or anxiety. Information and data received from the participant will inform the tailored treatment approach through machine learning. The purpose of this study is to compare different versions of the main IntelliCare Hub App (the centralized program delivery system) and participant user experience whether with the support of a coach or used independently. The randomized clinical trial (RCT) aims to obtain information on the feasibility and effectiveness of IntelliCare in improving symptoms of depression and anxiety.
Interventions
- BEHAVIORAL IntelliCare
- BEHAVIORAL Coaching
- BEHAVIORAL Hub App with the Recommender System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 301 participants |
| Start Date | 2016-07 |
| Est. Completion | 2018-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02801877
The ClinicalTrials.gov registry entry for NCT02801877 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 301 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which IntelliCare is the first listed.
NCT02801877 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02801877 about?
NCT02801877 is a clinical study titled "IntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for Depression". This study will evaluate and compare a smartphone intervention for depression and anxiety that uses machine learning to tailor treatment for participants with the same intervention without the machine learning component. The intervention, referred to as IntelliCare, delivers participant-specific tre...
What is the current status of trial NCT02801877?
This trial is currently completed. It is a NA study. The enrollment target is 301 participants. The study started on 2016-07. Estimated completion is 2018-01.
What interventions are being tested in trial NCT02801877?
The interventions under investigation include: IntelliCare (BEHAVIORAL), Coaching (BEHAVIORAL), Hub App with the Recommender System (BEHAVIORAL).
Who is sponsoring clinical trial NCT02801877?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.